FDA Inspection 1167555 — The Harvard Drug Group, LLC
The FDA completed an inspection of The Harvard Drug Group, LLC on Apr 4, 2022 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Memphis, TN (United States)